These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25487734)

  • 61. Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in Situ.
    Cu Y; Broderick KE; Banerjee K; Hickman J; Otten G; Barnett S; Kichaev G; Sardesai NY; Ulmer JB; Geall A
    Vaccines (Basel); 2013 Aug; 1(3):367-83. PubMed ID: 26344119
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Therapeutic perspectives of in vivo cell electropermeabilization.
    Mir LM
    Bioelectrochemistry; 2001 Jan; 53(1):1-10. PubMed ID: 11206915
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Electroporation of antibodies, DNA, and other macromolecules into cells: a highly efficient method.
    Baron S; Poast J; Rizzo D; McFarland E; Kieff E
    J Immunol Methods; 2000 Aug; 242(1-2):115-26. PubMed ID: 10986394
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Self-amplifying mRNA vaccines.
    Brito LA; Kommareddy S; Maione D; Uematsu Y; Giovani C; Berlanda Scorza F; Otten GR; Yu D; Mandl CW; Mason PW; Dormitzer PR; Ulmer JB; Geall AJ
    Adv Genet; 2015; 89():179-233. PubMed ID: 25620012
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Optimized in vivo transfer of small interfering RNA targeting dermal tissue using in vivo surface electroporation.
    Broderick KE; Chan A; Lin F; Shen X; Kichaev G; Khan AS; Aubin J; Zimmermann TS; Sardesai NY
    Mol Ther Nucleic Acids; 2012 Feb; 1(2):e11. PubMed ID: 23344722
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants.
    Flingai S; Czerwonko M; Goodman J; Kudchodkar SB; Muthumani K; Weiner DB
    Front Immunol; 2013 Nov; 4():354. PubMed ID: 24204366
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Elucidating the Kinetics of Expression and Immune Cell Infiltration Resulting from Plasmid Gene Delivery Enhanced by Surface Dermal Electroporation.
    Mendoza JM; Amante DH; Kichaev G; Knott CL; Kiosses WB; Smith TR; Sardesai NY; Broderick KE
    Vaccines (Basel); 2013 Aug; 1(3):384-97. PubMed ID: 26344120
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Recent innovations in mRNA vaccines.
    Ulmer JB; Geall AJ
    Curr Opin Immunol; 2016 Aug; 41():18-22. PubMed ID: 27240054
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The viability of DNA vaccines--marcus evans conference. 3-5 February 2004, London, UK.
    March JB
    IDrugs; 2004 Mar; 7(3):226-8. PubMed ID: 15017462
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Quantitative Proteomic Analysis of Cell Responses to Electroporation, a Classical Gene Delivery Approach.
    Zhao M; Zhao D; Ma Y; Hu Z; Wei Z
    Proteomics; 2018 Aug; 18(16):e1800127. PubMed ID: 30035351
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Impedance analysis of adherent cells after in situ electroporation-mediated delivery of bioactive proteins, DNA and nanoparticles in µL-volumes.
    Stolwijk JA; Wegener J
    Sci Rep; 2020 Dec; 10(1):21331. PubMed ID: 33288771
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Revisiting the role of pulsed electric fields in overcoming the barriers to in vivo gene electrotransfer.
    Sachdev S; Potočnik T; Rems L; Miklavčič D
    Bioelectrochemistry; 2022 Apr; 144():107994. PubMed ID: 34930678
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The promise of nucleic acid vaccines.
    Restifo NP; Ying H; Hwang L; Leitner WW
    Gene Ther; 2000 Jan; 7(2):89-92. PubMed ID: 10673713
    [TBL] [Abstract][Full Text] [Related]  

  • 74. DNA Vaccines 2008--A marcus evans Forum Bridging the Gap Between Technology and Application.
    Ulmer JB
    IDrugs; 2008 May; 11(5):322-4. PubMed ID: 18465669
    [No Abstract]   [Full Text] [Related]  

  • 75. Production of research-grade antibody by in vivo electroporation of DNA-encoding target protein.
    Okahara F; Itoh K; Ebihara M; Kobayashi M; Maruyama H; Kanaho Y; Maehama T
    Anal Biochem; 2005 Jan; 336(1):138-40. PubMed ID: 15582570
    [No Abstract]   [Full Text] [Related]  

  • 76. Recent Advances in Microscale Electroporation.
    Choi SE; Khoo H; Hur SC
    Chem Rev; 2022 Jul; 122(13):11247-11286. PubMed ID: 35737882
    [TBL] [Abstract][Full Text] [Related]  

  • 77. "Naked" DNA transfer technology for genetic vaccination against infectious disease.
    Fazio VM
    Res Virol; 1997; 148(2):101-8. PubMed ID: 9108608
    [No Abstract]   [Full Text] [Related]  

  • 78. Nucleic acid vaccines: an overview.
    Robinson HL
    Vaccine; 1997 Jun; 15(8):785-7. PubMed ID: 9234513
    [No Abstract]   [Full Text] [Related]  

  • 79. International meeting on the nucleic acid vaccines for the prevention of infectious disease and regulating nucleic acid (DNA) vaccines. Natcher Conference Center NIH, Bethesda, MD 5-8 February, 1996.
    Spier RE
    Vaccine; 1996 Sep; 14(13):1285-8. PubMed ID: 8961519
    [No Abstract]   [Full Text] [Related]  

  • 80. Workshop on the control and standardization of nucleic acid vaccines. Bethesda, Maryland, 8 February 1996.
    Smith HA; Goldenthal KL; Vogel FR; Rabinovich R; Aguado T
    Vaccine; 1997 Jun; 15(8):931-3. PubMed ID: 9340950
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.